An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
908 Devices, a pioneer in handheld and desktop devices for chemical and biochemical analysis, will participate in the Cowen 43rd Annual Healthcare Conference in Boston, MA. Management is scheduled for a fireside chat on Wednesday, March 8, at 9:50 a.m. ET. Interested parties can access a live and archived webcast of the presentation via the company website at www.908devices.com. The company focuses on life sciences, bioprocessing, and forensics, providing rapid analysis to address critical issues in various markets.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming Cowen 43rd Annual Healthcare Conference in Boston, MA.
908 Devices’ management is scheduled to host a fireside chat on Wednesday, March 8 at 9:50 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.908devices.com.
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.